Displaying 1 - 4 of 4 for Cancer - Brain
  • Glioblastoma (iCAR) Study (H-31973)
    • The purpose of this study is to find the largest safe dose of HER2-CAR T cells, to learn what the side effects are, and to see whether this experimental intervention might help patients with glioblastoma.
  • Glioblastoma Multiforme Study (H-37782)
    • This randomized phase II/III trial studies how well temozolomide and veliparib work compared to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.
  • REGN2810 Study (H-38961)
    • This is a phase 1, open-label, multicenter, ascending-dose escalation study of REGN2810, alone and in combination with other anti-cancer therapies in patients with advanced malignancies.
  • TACTASOM Study (H-35425)
    • This study uses special immune system cells called tumor-associated antigen (TAA)-specific cytotoxic T lymphocytes, a new experimental therapy to treat patients with a solid tumor which has come back or has not gone away after treatment.